Richter and Actavis Announce Positive Phase III Results for Cariprazine in the Prevention of Relapse in Patients with Schizophrenia
20/01/2015
Business related R&D trial Central Nervous System PARTNER - ALLERGAN / ABBVIE / ACTAVIS PRODUCT - VRAYLAR